Skip to content

LONA LONA Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Arvinas logo
ArvinasARVN
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
Erasca, Inc. logo
Erasca, Inc.ERAS
Immunome logo
ImmunomeIMNM

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's operating lease right-of-use assets in other assets?
LONA (LONA) reported operating lease right-of-use assets in other assets of $461K in Q1 2026.
How has LONA's operating lease right-of-use assets in other assets changed year-over-year?
LONA's operating lease right-of-use assets in other assets decreased by 38.0% year-over-year, from $743K to $461K.
What is the long-term trend for LONA's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), LONA's operating lease right-of-use assets in other assets has grown at a -10.6% compound annual growth rate (CAGR), from $936K to $535K.